Skip to main content
Erschienen in: Journal of Diabetes & Metabolic Disorders 1/2021

29.01.2021 | COVID-19 | Research article Zur Zeit gratis

Scientometric analyzing the output of researchers and organizations on COVID-19 for better conducting the scientific efforts: with a glance to endocrinology

verfasst von: Rasha Atlasi, Abdolreza Noroozi Chakoli, Aboozar Ramezani, Ozra Tabatabaei-Malazy, Bagher Larijani

Erschienen in: Journal of Diabetes & Metabolic Disorders | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Abstract

Purpose

As COVID-19 spreads rapidly and could affect the people and also lead to their death, especially individuals with underlying diseases, such as diabetes, the research community is also active in publishing novel research about it. Analyzing scientific outputs in this topic can represent an overview of publications. For this purpose, this study was conducted to determine status of publishing research works related to COVID-19 and analyzing the all documents published and indexed in Web of Science database and illustrate the co-occurrence and co-authority of hot papers in this documents.

Methodology

Our search strategy was based on using the related key terms including COVID-19, coronavirus, SARS2, etc., to find out all the published scientific works related to coronavirus disease indexed in web of science (WoS) in 2020. We then extracted the all hot papers and especially hot papers in endocrinology category and analyzed them. The data saved and imported in VOSviewer and ScientoPy programs for analysis and illustration of our data. We have shown our analysis in the tables, figures and maps.

Results

Totally, 56,402 records and 309 hot papers were retrieved. 3 of these hot papers were in endocrinology category. The most common type of publication was original papers followed by editorial papers in the second rank. The country with the most published documents was the USA followed by China. The journals of “British Medical Journal” and “Journal of Medical Virology” were ranked as the first and second sources, respectively. The “Harvard University” was the top organization with high proportion of scientific publications and “the Lancet” was the top-ranked journal that published highly-cited papers.

Conclusion

The literature on COVID-19 is increasing with a high and fast growth. In this regard, there is a need to evaluate these publications once in a while and their results should be published to use this information for more effective management of future research works with emphasizes on the gaps of researches and more citable documents and allocation of budgets on more needed research and don’t carry out the duplicates research. This would be helpful for prevention, control, and treatment of COVID-19 that is now among the most common topics in the world.
Literatur
1.
Zurück zum Zitat Chen Y, Liu Q, Guo D. Emerging coronaviruses: genome structure, replication, and pathogenesis. J Med Virol. 2020;92(4):418–23.CrossRef Chen Y, Liu Q, Guo D. Emerging coronaviruses: genome structure, replication, and pathogenesis. J Med Virol. 2020;92(4):418–23.CrossRef
2.
Zurück zum Zitat Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020;395(10224):565–74.CrossRef Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020;395(10224):565–74.CrossRef
3.
Zurück zum Zitat Hadi AG, Kadhom M, Hairunisa N, Yousif E, Mohammed SA. A review on COVID-19: origin, spread, symptoms, treatment, and prevention. Biointerface Res Appl Chem. 2020;10:7234–42.CrossRef Hadi AG, Kadhom M, Hairunisa N, Yousif E, Mohammed SA. A review on COVID-19: origin, spread, symptoms, treatment, and prevention. Biointerface Res Appl Chem. 2020;10:7234–42.CrossRef
4.
Zurück zum Zitat Dong E, Du H, Gardner L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis. 2020;20(5):533–4.CrossRef Dong E, Du H, Gardner L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis. 2020;20(5):533–4.CrossRef
5.
Zurück zum Zitat de Haan CA, Rottier PJ. Molecular interactions in the assembly of coronaviruses. Adv Virus Res. 2005;64:165–230.CrossRef de Haan CA, Rottier PJ. Molecular interactions in the assembly of coronaviruses. Adv Virus Res. 2005;64:165–230.CrossRef
6.
Zurück zum Zitat Guo Y-R, Cao Q-D, Hong Z-S, Tan Y-Y, Chen S-D, Jin H-J, et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak–an update on the status. Military Med Res. 2020;7(1):1–10.CrossRef Guo Y-R, Cao Q-D, Hong Z-S, Tan Y-Y, Chen S-D, Jin H-J, et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak–an update on the status. Military Med Res. 2020;7(1):1–10.CrossRef
7.
Zurück zum Zitat Belkacemi Y, Grellier N, Ghith S, Debbi K, Coraggio G, Bounedjar A, et al. A review of the international early recommendations for departments organization and Cancer management priorities during the global COVID-19 pandemic. Applicability in Low-and Middle-Income Countries. European J Cancer. 2020. Belkacemi Y, Grellier N, Ghith S, Debbi K, Coraggio G, Bounedjar A, et al. A review of the international early recommendations for departments organization and Cancer management priorities during the global COVID-19 pandemic. Applicability in Low-and Middle-Income Countries. European J Cancer. 2020.
8.
Zurück zum Zitat Onder G, Rezza G, Brusaferro S. Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy. Jama. 2020;323(18):1775–6.PubMed Onder G, Rezza G, Brusaferro S. Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy. Jama. 2020;323(18):1775–6.PubMed
9.
Zurück zum Zitat Yang X, Yu Y, Xu J, Shu H, Liu H, Wu Y, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020;8:475–81.CrossRef Yang X, Yu Y, Xu J, Shu H, Liu H, Wu Y, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020;8:475–81.CrossRef
10.
Zurück zum Zitat Zhang J-j, Dong X, Cao Y-y, Yuan Y-d, Yang Y-b, Yan Y-q, et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy. 2020;75(7):1730–1741. Zhang J-j, Dong X, Cao Y-y, Yuan Y-d, Yang Y-b, Yan Y-q, et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy. 2020;75(7):1730–1741.
13.
Zurück zum Zitat Motlagh A, Yamrali M, Azghandi S, Azadeh P, Vaezi M, Ashrafi F, et al. COVID19 prevention & care; a cancer specific guideline. Archives Iranian Med. 2020;23(4):255–64.CrossRef Motlagh A, Yamrali M, Azghandi S, Azadeh P, Vaezi M, Ashrafi F, et al. COVID19 prevention & care; a cancer specific guideline. Archives Iranian Med. 2020;23(4):255–64.CrossRef
14.
Zurück zum Zitat Park M, Cook AR, Lim JT, Sun Y, Dickens BL. A systematic review of COVID-19 epidemiology based on current evidence. J Clin Med. 2020;9(4):967.CrossRef Park M, Cook AR, Lim JT, Sun Y, Dickens BL. A systematic review of COVID-19 epidemiology based on current evidence. J Clin Med. 2020;9(4):967.CrossRef
15.
Zurück zum Zitat Cortegiani A, Ingoglia G, Ippolito M, Giarratano A, Einav S. A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19. J Crit Care. 2020. Cortegiani A, Ingoglia G, Ippolito M, Giarratano A, Einav S. A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19. J Crit Care. 2020.
16.
Zurück zum Zitat Rodriguez-Morales AJ, Cardona-Ospina JA, Gutiérrez-Ocampo E, Villamizar-Peña R, Holguin-Rivera Y, Escalera-Antezana JP, et al. Clinical, laboratory and imaging features of COVID-19: a systematic review and meta-analysis. Travel Med Infect Dis 2020;34:101623. Rodriguez-Morales AJ, Cardona-Ospina JA, Gutiérrez-Ocampo E, Villamizar-Peña R, Holguin-Rivera Y, Escalera-Antezana JP, et al. Clinical, laboratory and imaging features of COVID-19: a systematic review and meta-analysis. Travel Med Infect Dis 2020;34:101623.
17.
Zurück zum Zitat Lou J, Tian S-J, Niu S-M, Kang X-Q, Lian H-X, Zhang L-X, et al. Coronavirus disease 2019: a bibliometric analysis and review. Eur Rev Med Pharmacol Sci. 2020;24(6):3411–21.PubMed Lou J, Tian S-J, Niu S-M, Kang X-Q, Lian H-X, Zhang L-X, et al. Coronavirus disease 2019: a bibliometric analysis and review. Eur Rev Med Pharmacol Sci. 2020;24(6):3411–21.PubMed
18.
Zurück zum Zitat Chahrour M, Assi S, Bejjani M, Nasrallah AA, Salhab H, Fares M, et al. A bibliometric analysis of Covid-19 research activity: A call for increased output. Cureus. 2020;12(3):e7357. Chahrour M, Assi S, Bejjani M, Nasrallah AA, Salhab H, Fares M, et al. A bibliometric analysis of Covid-19 research activity: A call for increased output. Cureus. 2020;12(3):e7357.
19.
Zurück zum Zitat Dehghanbanadaki H, Seif F, Vahidi Y, Razi F, Hashemi E, Khoshmirsafa M, et al. Bibliometric analysis of global scientific research on coronavirus (COVID-19). Med J Islamic Republ Iran (MJIRI). 2020;34(1):354–62. Dehghanbanadaki H, Seif F, Vahidi Y, Razi F, Hashemi E, Khoshmirsafa M, et al. Bibliometric analysis of global scientific research on coronavirus (COVID-19). Med J Islamic Republ Iran (MJIRI). 2020;34(1):354–62.
20.
Zurück zum Zitat Shamsi A, Mansourzadeh MJ, Ghazbani A, Khalagi K, Fahimfar N, Ostovar A. Contribution of Iran in COVID-19 studies: a bibliometrics analysis. J Diabetes Metab Disord 2020:1–10. Shamsi A, Mansourzadeh MJ, Ghazbani A, Khalagi K, Fahimfar N, Ostovar A. Contribution of Iran in COVID-19 studies: a bibliometrics analysis. J Diabetes Metab Disord 2020:1–10.
21.
Zurück zum Zitat Liu N, Chee ML, Niu C, Pek PP, Siddiqui FJ, Ansah JP, et al. Coronavirus Disease 2019 (COVID-19): an evidence map of medical literature. medRxiv. 2020;1–10. Liu N, Chee ML, Niu C, Pek PP, Siddiqui FJ, Ansah JP, et al. Coronavirus Disease 2019 (COVID-19): an evidence map of medical literature. medRxiv. 2020;1–10.
22.
Zurück zum Zitat Tran BX, Ha GH, Nguyen LH, Vu GT, Hoang MT, Le HT, et al. Studies of novel coronavirus disease 19 (COVID-19) pandemic: a global analysis of literature. Int J Environ Res Public Health. 2020;17(11):4095.CrossRef Tran BX, Ha GH, Nguyen LH, Vu GT, Hoang MT, Le HT, et al. Studies of novel coronavirus disease 19 (COVID-19) pandemic: a global analysis of literature. Int J Environ Res Public Health. 2020;17(11):4095.CrossRef
23.
Zurück zum Zitat DE Felice F, Polimeni A. Coronavirus Disease (COVID-19). Machine Learn Bibliometric Analys In Vivo. 2020;34(3 suppl):1613–7. DE Felice F, Polimeni A. Coronavirus Disease (COVID-19). Machine Learn Bibliometric Analys In Vivo. 2020;34(3 suppl):1613–7.
24.
Zurück zum Zitat Purcell LN, Charles AG. An Invited Commentary on World Health Organization declares global emergency: A review of the 2019 novel Coronavirus (COVID-19): Emergency or new reality? Int J Surg (London, England). 2020;76:111.CrossRef Purcell LN, Charles AG. An Invited Commentary on World Health Organization declares global emergency: A review of the 2019 novel Coronavirus (COVID-19): Emergency or new reality? Int J Surg (London, England). 2020;76:111.CrossRef
25.
Zurück zum Zitat W-j G, Ni Z-y, Hu Y, Liang W-h, Ou C-q, He J-x, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708–20.CrossRef W-j G, Ni Z-y, Hu Y, Liang W-h, Ou C-q, He J-x, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708–20.CrossRef
Metadaten
Titel
Scientometric analyzing the output of researchers and organizations on COVID-19 for better conducting the scientific efforts: with a glance to endocrinology
verfasst von
Rasha Atlasi
Abdolreza Noroozi Chakoli
Aboozar Ramezani
Ozra Tabatabaei-Malazy
Bagher Larijani
Publikationsdatum
29.01.2021
Verlag
Springer International Publishing
Schlagwort
COVID-19
Erschienen in
Journal of Diabetes & Metabolic Disorders / Ausgabe 1/2021
Elektronische ISSN: 2251-6581
DOI
https://doi.org/10.1007/s40200-020-00718-7

Weitere Artikel der Ausgabe 1/2021

Journal of Diabetes & Metabolic Disorders 1/2021 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.